Etretinate (Ro 10-9359) prevents autoimmune syndrome associated with chronic graft-versus-host disease in rats.
Stosić-Grujicić
S
S
Institute for Biological Research Siniśa Stanković, Clinical Hospital Centre Zemun, Belgrade, Yugoslavia.
Ejdus
L
L
Mijatović
S
S
Jovanović
S
S
Ostojić
N S
NS
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001327:Autoimmune Diseases / Q000276:immunology / Q000517:prevention & control*; D001786:Blood Glucose / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D016827:CD8 Antigens / Q000276:immunology / Q000502:physiology; D005050:Etretinate / Q000494:pharmacology*; D005951:Glucose Tolerance Test; D006086:Graft vs Host Disease / Q000097:blood / Q000276:immunology*; D017710:Lymphocyte Transfusion; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen / Q000276:immunology; D013577:Syndrome; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D001786:Blood Glucose; D016827:CD8 Antigens; D005050:Etretinate